期刊文献+

N-甲基-D-天冬氨酸受体NR1亚基口服基因疫苗的制备和激活SD大鼠产生循环抗体的初步报告 被引量:1

A Preliminary Report of the Production of Oral Vaccine Carrying the NR1 Gene and Its Role on Producing NR1 Antibodies in SD Rats
下载PDF
导出
摘要 目的 研制携带 N-甲基 -D-天冬氨酸受体 1 ( N-methyl,D-aspartate receptor subunit1 ,NR1 )的口服疫苗 ,探讨疫苗激活 SD大鼠产生循环抗体的可能性。方法 采用聚合酶链反应、酶切连接和蓝白筛选的方法构建NR1的表达载体 ;以磷酸钙共沉淀的方法转染 HEK2 93细胞 ,并用 G41 8筛选阳性细胞克隆 ;应用逆转录聚合酶链反应和免疫荧光细胞染色方法鉴定阳性细胞株 ;经氯化钙法制备携带 NR1表达载体的减毒鼠伤寒沙门 (氏 )菌口服疫苗 ( SL-NR1 ) ;胃内灌注 60 0 μL、D( λ) 2 6 0 nm为 0 .6的 S L-NR1 ,2周内 4次给药 ;以阳性细胞株为靶细胞 ,用免疫荧光方法检测大鼠循环中 NR1抗体滴度。结果 扩增出 NR1基因并构建了含有 NR1基因的表达载体—— p CDNA3 .1 -NR1 ;建立了细胞株 HEK 2 93 -NR1 ;证实口服疫苗可激活 SD大鼠 ( 2 3 /2 5只 )产生 NR1抗体。结论 成功研制了携带 NR1基因的口服减毒鼠伤寒沙门 (氏 )菌活疫苗 ,其可激活机体免疫反应产生 NR1抗体。 Objective To produce the oral vaccine carrying NMDAR NR1,and explore whether it can induce circular antibodies in SD rats. Methods Polymerase chain reaction,digestion of endonucelease and ligation,blue-white selection were used to construct the expression vector;Ca 3(PO 4) 2 method was used to transfect HEK293 cell,G418 to select positive cell clone;reverse-transcription PCR and immunofluresene cell staining were used to testify positive cell strain;the method of CaCl 2 toproduceoralvaccineofattenuatedSalmonella typhimurium carrying NR1(SL-NR1);when D(λ) 260 nm equal 0.6,600 μL of SL-NR1 was given to the SD rat intragastrically,4 times per 2 weeks;the positive cell strain as target cell,use immunofluresence method to detect the level of antibody in rat blood circulation. Results NR1 was amplified by PCR method; the expression vector containing NR1: pCDNA3.1-NR1 was constructed;the cell line——HEK 293-NR1 was established;the oral vaccine could elicite 23/25 SD rats to produce NR1 antibodies. Conclusions The attenuated Salmonella oral vaccine carrying NR1 gene is produced successfully and it can activate the immune response of rat to produce NR1 antibodies.
出处 《中国神经免疫学和神经病学杂志》 CAS 2004年第4期224-226,238,共4页 Chinese Journal of Neuroimmunology and Neurology
基金 国家自然科学基金资助课题 ( 3 0 2 713 3 0 3 0 170 960 )
关键词 N-甲基-D-天冬氨酸受体NR1亚基 口服疫苗 循环抗体 NMDAR1 NR1 subunit oral vaccine NR1 antibody
  • 相关文献

参考文献6

  • 1Nemunaitis J,Cunningham C,Senzer N,et al.Pilot trial of genetically modified,attenuated Salmonella expressing the E.coli cytosine deaminase gene in refractory cancer patients[J].Cancer Gene Ther,2003,10(10):737-744.
  • 2Eling JW,Sulter GA,Kaste M,et al.AMPA antagonist ZK200775 in patients with acute ischemic stroke:possible glial cell toxicity detected by monitoring of S-100 level[J].Stroke,2002,33(12):2813-2818.
  • 3Massieu L,Garcia O.The role of excitotoxicity and metabolic failure in the pathogenesis of neurological disorders[J].Neurobiology,1998,6(1):99-108.
  • 4During MJ,Symes CW,Lawlor PA,et al.An oral vaccine against NMDAR1 with efficiency in experimental stroke and epilepsy[J].Science,2000,287(1457):1453-1460.
  • 5Urabe M,Ding C,Kotin RM.Insect cells as a factory to produce adeno-associated virus type 2 vectors[J].Hum Gene Ther,2002,13(16):1935-1943.
  • 6Toso JF,Gill VJ,Hwu P,et al.Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma[J].J Clin Oncol,2002,20(1):142-152.

同被引文献15

  • 1Camdessanch6 JP, Streichenberger N, Cavillon G, et al. Brain immunohistopathological study in a patient with anti-NMDAR encephalitis[ J]. Eur J Neurol, 2011, 18(6) : 929 -931.
  • 2Fitzgerald PJ. The NMDA receptor may participate in widespread suppression of circuit level neural activity, in addition to a similarly prominent role in circuit level activation [ J ]. Behav Brain Res, 2012, 230(1) : 291 -298.
  • 3Cull-Candy S, Brickley S, Farrant M. NNDA receptor subunits: diversity, development and disease [ J]. Curr Opin Neurobiol, 2001, 11(3) : 327 -335.
  • 4] During M J, Symes CW, Lawlor PA, et al. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy [ J ]. Science, 2000, 287 (25) : 1453 - 1460.
  • 5Hawkins LM, Chazot PL, Stephenson FA. Biochenmical evidence for the co-association of three N-methyl-D-asparate (NMDA) R2 subunits in recombinant NMDA receptors [ J]. J Biol Chem, 1999, 274(38) : 27211 -27218.
  • 6孙长凯.人NMDA受体主亚基M3M4环靶片段自身免疫抗兴奋毒性神经保护研究[D].北京:中国人民解放军军事医学科学院生物学博士后流动站,2000.12-2003.08.
  • 7Boado R,I, Zhang Y, Wang Y, et al. Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse[J]. Biotechnol Bioeng, 2009, 102 (4) : 1251 -1258.
  • 8Daniels TR, Bemabeu E, Rodrfguez JA, et al. The tmnsferrin receptor and the targeted delivery of therapeutic agents agairt rleer E J ]. Biochim Biophys Acta, 2012, 1820(3) : 291 -317.
  • 9Boado R J, Zhang Y, Zhang Y, et al . Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier [ J ]. Biotechnol Bioeng, 2008, 99 ( 2 ) : 475 - 484.
  • 10Sumbria RK, Boado R J, Pardridge WM. Brain protection from stroke with intravenous TNF-ct decoy receptor-Trojan horse fusion protein J]. Cereb Blood Flow Metab, 2012, 32(10) : 1933 -1938.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部